Literature DB >> 12969605

EMS defibrillation-first policy may not improve outcome in out-of-hospital cardiac arrest.

Martin Stotz1, Roland Albrecht, Gallus Zwicker, Juergen Drewe, Wolfgang Ummenhofer.   

Abstract

OBJECTIVE: Early defibrillation using automated external defibrillators (AEDs) has been advocated to improve survival in witnessed out-of-hospital cardiac arrest (OHCA) due to pulseless ventricular tachycardia (VT) and ventricular fibrillation (VF). However, when VT/VF is untreated and prolonged for more than a few minutes, defibrillation using AEDs may fail.
METHODS: This retrospective study reviewed the charts from local emergency medical service (EMS) between the years 1993 to 2001 to evaluate the value of the AED after its introduction into our EMS. All witnessed OHCA due to VT/VF were analysed; cases of collapse witnessed by EMS were excluded. The primary endpoint was defined as survival to hospital discharge and at 1-year follow-up, and the secondary endpoint as survival without major neurological deficit. A total of 76 patients were treated for witnessed VT/VF before the implementation of the AED and 92 patients after its implementation.
RESULTS: Before the introduction of paramedic AED defibrillation, physician defibrillation was performed at 15.6 min (+/-5.5, S.D.). After the introduction of AED defibrillation, paramedic defibrillation was performed at 5.7 min (+/-2.4, S.D.); the mean response interval from the call to defibrillation was shortened significantly (P<0.001). At the same time, survival to hospital discharge decreased from 23.7% (18/76 patients) to 14.1% (13/92) (P=0.112) and at 1-year follow-up from 17.1% (13/76) to 9.8% (9/92) (P=0.161). Favourable neurological outcome at 1-year follow-up also decreased from 14.5% (11/76) to 8.7% (8/92) (P=0.239).
CONCLUSION: Implementation of the AED did not improve survival or a favourable neurological outcome in patients with OHCA due to VF/VT. However, with 5.7 min time to defibrillation, our EMS did not meet the criteria for early defibrillation. For prolonged periods of VT/VF, initial basic life support (BLS) may be superior to immediate AED. If response times of <4 min cannot be attained by the emergency systems, reconsidering of resuscitation algorithms seems to be advisable.

Entities:  

Mesh:

Year:  2003        PMID: 12969605     DOI: 10.1016/s0300-9572(03)00271-5

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Basic life support knowledge of healthcare students and professionals in the Qassim University.

Authors:  Abdulrahman Almesned; Ahmad Almeman; Ali Mohammad Alakhtar; Abdulmajeed Abdulkarim AlAboudi; Ahmed Zabin Alotaibi; Yazeed Abdullah Al-Ghasham; Mohammed Saleh Aldamegh
Journal:  Int J Health Sci (Qassim)       Date:  2014-04

2.  Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Jasmeet Soar; Mary E Mancini; Farhan Bhanji; John E Billi; Jennifer Dennett; Judith Finn; Matthew Huei-Ming Ma; Gavin D Perkins; David L Rodgers; Mary Fran Hazinski; Ian Jacobs; Peter T Morley
Journal:  Resuscitation       Date:  2010-10       Impact factor: 5.262

3.  Treating the clock and not the patient: ambulance response times and risk.

Authors:  L Price
Journal:  Qual Saf Health Care       Date:  2006-04

Review 4.  Ventricular fibrillation and defibrillation.

Authors:  P Jones; N Lodé
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

Review 5.  [Transthoracic defibrillation. Physiologic and pathophysiologic principles and their role in the outcome of resuscitation].

Authors:  V Lischke; P Kessler; C Byhahn; K Westphal; A Amann
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

Review 6.  Response time as a sole performance indicator in EMS: Pitfalls and solutions.

Authors:  Sultan Zayed Khalifah Al-Shaqsi
Journal:  Open Access Emerg Med       Date:  2010-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.